SCHEMBL5731992

SCHEMBL5731992

CCOC(=O)c1ncsc1Sc1ccccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.55
POLB P06746 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 6/20 0.46
MAPT P10636 7/20 0.41
KDM4E B2RXH2 6/20 0.41
PKM P14618 1/20 0.41
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
CASP1 P29466 1/20 0.40
ADORA1 P30542 1/20 0.40
CDC7 O00311 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 2/20 0.39
ILK Q13418 1/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5732391 0.79 ALDH1A1 (0.56) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL5732119 0.77 ALDH1A1 (0.54) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL27768167 0.76 ALDH1A1 (0.49) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL24101302 0.75 IDO1 (0.45) ALDH1A1MAPTKDM4ECASP1MEN1
SCHEMBL5731900 0.75 ALDH1A1 (0.54) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL16345888 0.74 KDM4E (0.39) ALDH1A1MAPK1HSD17B10MAPTKDM4E
SCHEMBL5731996 0.74 ALDH1A1 (0.56) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL9131623 0.73 ALDH1A1 (0.69) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL1179173 0.72 ALDH1A1 (0.49) ALDH1A1POLBMAPK1HSD17B10MAPT
SCHEMBL5731402 0.71 ALDH1A1 (0.50) ALDH1A1POLBMAPK1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270656-A1 Substituted piperazines of azepines, oxazepines and thiazepines ELI LILLY AND COMPANY 2006-11-30 US disclosed
EP-1664063-A1 SUBSTITUTED PIPERAZINES OF AZEPINES, OXAZEPINES, AND THIAZEPINES ELI LILLY AND COMPANY (US) 2006-06-07 EP disclosed
WO-2005026177-A1 SUBSTITUTED PIPERAZINES OF AZEPINES, OXAZEPINES, AND THIAZEPINES ELI LILLY AND COMPANY (US) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270656-A1 Substituted piperazines of azepines, oxazepines and thiazepines HRH4, HRH2, HRH3 ALDH1A1 2523/4885POLB 4011/4885MAPK1 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.